Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 173
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Article in Chinese | MEDLINE | ID: mdl-36229219

ABSTRACT

Fish bile poisoning may damage human liver and kidney, causing degeneration and necrosis. Can also damage brain cells and heart muscle, resulting in nervous system and cardiovascular system lesions. This paper reports a case of a patient who developed multiple organ dysfunction syndrome (MODS) after oral administration of fish bile with Xiexin folk prescription for eye disease. In January 2020, he went to the poisoning and occupational diseases department of the emergency department of Qilu hospital. After receiving hemoperfusion, continuous renal replacement therapy (CRRT) and symptomatic support treatment, the patient was improved and discharged. CRRT combined with HP is one of the rapid and effective methods for the treatment of acute fish bile poisoning.


Subject(s)
Hemoperfusion , Poisoning , Animals , Gallbladder , Humans , Kidney , Liver , Male , Multiple Organ Failure , Poisoning/complications
2.
Article in Chinese | MEDLINE | ID: mdl-36052592

ABSTRACT

Mistakenly picking and eating poisonous mushrooms can cause acute poisoning. In August 2020, Qingdao Hospital of Traditional Chinese Medicine handled a poisonous mushroom poisoning incident, conducted epidemiological investigation on all poisoned patients, collected suspicious food, clinical manifestations, clinical test results and treatment conditions, and identified the mushrooms as Amanita fuliginea poisoning after morphological identification. In this incident, 6 people ate grey goose paste, of which 4 were sick with a incubation period of 6~12 h. The clinical manifestations were gastrointestinal symptoms such as nausea, vomiting and diarrhea, liver and kidney damage. After symptomatic support treatment, hemoperfusion or continuous hemofiltration treatment, the patients were cured and discharged. It is suggested to strengthen the popular science education on poisonous mushroom poisoning and improve the ability of identification and clinical treatment of poisonous mushrooms in grass-roots medical institutions.


Subject(s)
Hemoperfusion , Mushroom Poisoning , Amanita , Humans , Liver , Mushroom Poisoning/diagnosis , Mushroom Poisoning/epidemiology , Mushroom Poisoning/therapy
4.
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi ; 39(12): 952-953, 2021 Dec 20.
Article in Chinese | MEDLINE | ID: mdl-35164430

ABSTRACT

Nifedipine is a typical dihydropyridine calcium antagonist, and large doses of intake can cause poisoning. This article retrospectively analyzed the clinical data of a patient with nifedipine poisoning complicated with paralytic intestinal obstruction admitted to the First Affiliated Hospital of Jilin University in October 2020. When the patient was admitted to the hospital, the symptoms of poisoning were decreased blood pressure and shock, followed by severe paralytic intestinal obstruction. Finally, after active hemoperfusion combined with hemofiltration and symptomatic supportive treatment, the patient's condition improved and was discharged. There was no discomfort in the follow-up 2 months later.


Subject(s)
Hemofiltration , Hemoperfusion , Intestinal Obstruction , Poisoning , Humans , Nifedipine , Poisoning/therapy , Retrospective Studies
5.
Ann Palliat Med ; 9(4): 2152-2162, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32692225

ABSTRACT

BACKGROUND: Paraquat (PQ) is a herbicide that is highly toxic to humans and animals. Xuebijing can regulate immune and inflammatory mediators. Blood purification is a conventional treatment for paraquat poisoning. Therefore, this study aimed to investigate the clinical effect of Xuebijing combined with hemoperfusion on acute paraquat poisoning (APQ). METHODS: The PubMed, Cochrane Library, EMbase, CNKI, CBM, and Wanfang databases were searched by computer for randomized controlled trials (RCT) of Xuebijing combined with hemoperfusion in the treatment of APQ. The search time was from the establishment of database to April 2020. The documents were screened and extracted according to the inclusion and exclusion criteria. Meta-analysis and Revman 5.3 were used to evaluate the quality. RESULTS: The metanalysis included 10 studies, totaling 636 patients. Results showed that the 7-day survival rate of Xuebijing combined with hemoperfusion group was higher than that of the control group [hazard ratio (HR) =1.17, 95% confidence interval (CI): (1.04, 1.32), P<0.008], while 14-day survival rate was higher [HR =1.52, 95% CI: (1.13, 2.06), P<0.006], alanine aminotransferase (ALT) was lower [mean difference (MD) =-32.5, 95% CI: (-52.24, -12.76), P=0.001], creatinine was lower [MD =-60.73, 95% CI: (-103.42, -18.04), P<0.005], oxygen partial pressure (PaO2) was higher [MD =6.21, 95% CI: (1.78, 10.64), P=0.006], and C-reactive protein (CRP) was lower [MD =-6.15, 95% CI: (-7.14, -5.16), P<0.00001]. However, there was no statistical difference in oxygen saturation (SpO2) and carbon dioxide PaO2 between the two groups. CONCLUSIONS: Xuebijing combined with hemoperfusion and conventional treatment can improve the 7-day and 14-day survival rate, oxygenation level, liver and kidney function, and inflammatory response of paraquat poisoning (PQ) patients.


Subject(s)
Drugs, Chinese Herbal , Hemoperfusion , Animals , Drugs, Chinese Herbal/therapeutic use , Humans , Paraquat , Proportional Hazards Models
6.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue ; 32(2): 240-242, 2020 Feb.
Article in Chinese | MEDLINE | ID: mdl-32275015

ABSTRACT

At present, there is no specific antidote for colchicine intoxication, and 0.8 mg/kg is its lethal dose. The prognosis of colchicine intoxication patients is closely related to the dosage, but the individual difference is very great. A 38-year-old man with colchicine poisoning was admitted to the Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, who had ingested 80 mg colchicine tablets (1.19 mg/kg) orally for 4 hours. He was immediately put on gastric lavage, enema, and catharsis. Continuous blood purification was performed for 34 hours and 22 minutes, with a combination of hemoperfusion (HP) and continuous veno-venous hemofiltration dialysis (CVVHDF). He also received a large dose of the glucocorticoid with 80 mg of methylprednisolone injected intravenously every 8 hours and organ function support. The patient was hospitalized for 2 weeks and discharged with improvement. The successful treatment of this case was reported for reference.


Subject(s)
Colchicine/poisoning , Hemoperfusion , Poisoning/therapy , Adult , China , Hemofiltration , Humans , Male , Prognosis , Renal Dialysis
7.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue ; 30(7): 695-698, 2018 Jul.
Article in Chinese | MEDLINE | ID: mdl-30045801

ABSTRACT

OBJECTIVE: To investigate the efficacy of prussian blue (PB) or its combination with hemoperfusion (HP) in the treatment of acute thallium poisoning. METHODS: Forty-seven patients with acute thallium poisoning with complete data hospitalized in the 307th Hospital of PLA from September 2002 to December 2017 were enrolled, and they were divided into mild poisoning group (blood thallium < 150 µg/L, urinary thallium < 1 000 µg/L) and moderate-severe poisoning group (blood thallium ≥ 150 µg/L, urinary thallium ≥ 1 000 µg/L) according to the toxic degrees. All patients were given symptomatic supportive treatments such as potassium supplementation, catharsis, vital organ protections, neurotrophic drugs, and circulation support. The mild poisoning patients were given PB with an oral dose of 250 mg×kg-1×d-1, while moderate-severe poisoning patients were given PB combined HP continued 2-4 hours each time. The PB dose or frequency of HP application was adjusted according to the monitoring results of blood and urine thallium. Data of gender, age, pain grading (numeric rating scale NRS), clinical manifestations, blood and urine thallium before and after treatment, length of hospitalization and prognosis were collected. RESULTS: Of the 47 patients, patients with incomplete blood and urine test results, and used non-single HP treatment such as plasmapheresis and hemodialysis for treatment were excluded, and a total of 29 patients were enrolled in the analysis. (1) Among 29 patients, there were 20 males and 9 females, median age of 40.0 (34.0, 49.0) years old; the main clinical manifestations were nervous system and alopecia, some patients had digestive system symptoms. There were 13 patients (44.8%) in the mild poisoning group with painless (grade 0) or mild pain (grade 1-3) with mild clinical symptoms, the length of hospitalization was 17.0 (14.2, 21.5) days. There were 16 patients (55.2%) in the moderate-severe poisoning group with moderate pain (grade 4-6) or severe pain (grade 7-10) with severe clinical symptoms, the length of hospitalization was 24.0 (18.0, 29.0) days. (2) After treatment, the thallium concentrations in blood and urine in the mild poisoning group were significantly lower than those before treatment [µg/L: blood thallium was 0.80 (0, 8.83) vs. 60.00 (40.00, 120.00), urine thallium was 11.30 (0, 70.10) vs. 370.00 (168.30, 610.00), both P < 0.01], the thallium concentrations in blood and urine in the moderate-severe poisoning group were also significantly lower than those before treatment [µg/L: blood thallium was 6.95 (0, 50.50) vs. 614.50 (245.00, 922.00), urinary thallium was 20.70 (1.95, 283.00) vs. 5 434.00 (4 077.20, 10 273.00), both P < 0.01]. None of the 29 patients died, and their clinical symptoms were improved significantly. All the 27 patients had good prognosis without sequela in half a year follow-up, and 2 patients with severe acute thallium poisoning suffered from nervous system injury. CONCLUSIONS: In the acute thallium poisoning patients, on the basis of general treatment, additional PB in mild poisoning group and PB combined with HP in moderate-severe poisoning group can obtain satisfactory curative effects.


Subject(s)
Thallium/poisoning , Adult , Female , Ferrocyanides , Heavy Metal Poisoning , Hemoperfusion , Humans , Male , Middle Aged
8.
Nan Fang Yi Ke Da Xue Xue Bao ; 38(5): 635-638, 2018 May 20.
Article in Chinese | MEDLINE | ID: mdl-29891465

ABSTRACT

We report the clinical characteristics, treatments and outcomes of 4 rare cases of mixed amanita fuliginea and amanita rimosa poisoning with rhabdomyolysis, and review the research progress in the intoxication mechanism and treatment. The latent time of amanita poisoning, defined as the period from the ingestion of poisonous mushroom to the onset of gastrointestinal symptoms, was about 8 days, and the severity of poisoning was associated with the amount of mushroom ingested. All the 4 patients developed multiple organ dysfunctions within 3 to 4 days after mushroom ingestion, predominantly in the liver, kidney and central nervous system accompanied with acute gastrointestinal injury and rhabdomyolysis. The treatment measures included persistent hemofiltration and intermittent hemoperfusion once daily for 5-7 days, and plasma exchange was administered in 2 cases for 1 or 2 times. High-dose vitamin C, glucose and corticosteroid were also given to the patients. After the treatments, two patients were cured and the other two died due to an excess intake of poisonous mushroom and lack of early preemptive therapies. Early emetic, gastric lavage, catharsis, fluid infusion and diuresis are critical to interrupt the enterohepatic circulation of amanita phalloides toxins and prevent the development of multiple organ dysfunction. Enhanced hemofiltration and sequential plasma therapy might effectively eliminate toxin from the blood to protect against further organ damages.


Subject(s)
Multiple Organ Failure/etiology , Mushroom Poisoning/complications , Rhabdomyolysis/etiology , Amanita , Hemofiltration , Hemoperfusion , Humans , Multiple Organ Failure/prevention & control , Mushroom Poisoning/therapy , Rhabdomyolysis/therapy , Time Factors , Treatment Outcome
10.
Transplant Proc ; 50(1): 192-197, 2018.
Article in English | MEDLINE | ID: mdl-29407307

ABSTRACT

INTRODUCTION: Amanita phalloides poisoning is a potentially fatal cause of acute liver failure. The aim of this study was to analyze the impact of initial patients' characteristics and different treatment modalities on the outcome of patients with liver failure caused by Amanita poisoning. MATERIAL AND METHODS: We retrospectively evaluated 23 patients admitted to our center between July 2007 and August 2016. RESULTS: Mean time interval between Amanita phalloides ingestion and the onset of gastrointestinal symptoms was 12.48 ± 9.88 hours and the interval between ingestion and hospital admission 26.26 ± 15.14 hours. The treatment was intiated by oral decontamination using activated charcoal followed by intravenous rehydration and high doses of intravenous N-acetylcysteine and silibinin. Fourteen patients (61%) underwent extracorporeal elimination method. Ten patients had plasmapheresis, 1 patient had hemoperfusion, and 5 patients had fractionated plasma separation and adsorption. Seven patients who met King's College Criteria were listed for urgent liver transplantation; one of them died before transplantation. Six patients underwent liver transplantation; the mean waiting time was 6.5 ± 12.0 days (range, 1-31 days). One patient died 2 months afterward. All 16 patients who did not meet King's College Criteria and received conservative treatment survived. CONCLUSION: Our results documented a good prognostic value of standard King's College Criteria for indication of urgent liver transplantation in acute liver failure caused by Amanita phalloides poisoning. Fractionated plasma separation and adsorption may contribute to low mortality on the waiting list. Intensive care and extracorporeal elimination methods seem to be crucial points of the conservative treatment.


Subject(s)
Conservative Treatment/methods , Critical Care/methods , Liver Failure, Acute/therapy , Mushroom Poisoning/therapy , Severity of Illness Index , Acetylcysteine/administration & dosage , Adult , Amanita , Antidotes/administration & dosage , Antioxidants/administration & dosage , Charcoal/administration & dosage , Female , Fluid Therapy/methods , Hemoperfusion/methods , Humans , Liver Failure, Acute/etiology , Liver Transplantation/methods , Male , Middle Aged , Mushroom Poisoning/complications , Plasmapheresis/methods , Prognosis , Renal Dialysis/methods , Retrospective Studies , Silybin , Silymarin/administration & dosage , Treatment Outcome , Waiting Lists/mortality
11.
Biomacromolecules ; 19(6): 1966-1978, 2018 06 11.
Article in English | MEDLINE | ID: mdl-29425448

ABSTRACT

The currently used hemoperfusion adsorbents such as activated carbon and ion-exchange resin show dissatisfactory hemocompatibility, and a large dose of injected heparin leads to the increasing cost and the risk of systematic bleeding. Natural polysaccharide adsorbents commonly have good biocompatibility, but their application is restricted by the poor mechanical strength and low content of functional groups. Herein, we developed an efficient, self-anticoagulant and blood compatible hemoperfusion adsorbent by imitating the structure and functional groups of heparin. Carrageenan and poly(acrylic acid) (PAA) cross-linked networks were built up by the combination of phase inversion of carrageenan and post-cross-linking of AA, and the formed dual-network structure endowed the beads with improved mechanical properties and controlled swelling ratios. The beads exhibited low protein adsorption amounts, low hemolysis ratios, low cytotoxicity, and suppressed complement activation and contact activation levels. Especially, the activated partial thromboplastin time, prothrombin time, and thrombin time of the gel beads were prolonged over 13, 18, and 4 times than those of the control. The self-anticoagulant and biocompatible beads showed good adsorption capacities toward exogenous toxins (560.34 mg/g for heavy metal ions) and endogenous toxins (14.83 mg/g for creatinine, 228.16 mg/g for bilirubin, and 18.15 mg/g for low density lipoprotein (LDL)), thus, highlighting their potential usage for safe and efficient blood purification.


Subject(s)
Anticoagulants/pharmacology , Biomimetic Materials/chemistry , Carrageenan/chemistry , Hemoperfusion/instrumentation , Heparin/chemistry , Acrylic Resins/chemistry , Anticoagulants/chemistry , Biomimetic Materials/pharmacology , Complement Activation/drug effects , Copper/chemistry , Copper/isolation & purification , Gels/chemistry , Hemoperfusion/methods , Humans , Lipoproteins, LDL/chemistry , Materials Testing/methods , Microscopy, Electron, Scanning , Partial Thromboplastin Time , Spectroscopy, Fourier Transform Infrared , Thermogravimetry , Thrombin Time , Young Adult
12.
Medicine (Baltimore) ; 96(12): e6160, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28328802

ABSTRACT

This study aims to investigate the efficacy and safety of neutral macroporous resin hemoperfusion in treating maintenance hemodialysis (MHD) patients with refractory uremic pruritus (RUP).Ninety patients were enrolled and were randomly divided into 3 groups: control group, experiment 1 group, and experiment 2 group. Clinical symptom scores of skin itching were recorded before and at 4 and 8 weeks after the treatment. In addition, serum parathyroid hormone (PTH), calcium (Ca), phosphorus (P), and C-reactive protein (CRP) were detected; and the calcium-phosphorus product ([Ca] × [P]) was calculated to compare the curative effect.VSA score, modified Duo pruritus score, and CRP: these indices decreased to some extent at 4 and 8 weeks after treatment in the 2 experiment groups, compared with pretreatment (P < 0.05); and differences among these 3 groups were statistically significant (P < 0.05). PTH, P, and [Ca] × [P]: these indices decreased to some extent at 4 and 8 weeks after treatment in the 2 experiment groups, compared with pretreatment (P < 0.05); and differences between the control and experiment 1 groups, as well as between the control and experiment 2 groups, were statistically significant (P < 0.05). However, the difference between the experiment 1 and experiment 2 groups were not statistically significant (P < 0.05).The effects of HA330 and HA130 resin hemoperfusion apparatus on secondary hyperparathyroidism and the disorder of calcium and phosphorus metabolism are similar. The mechanism may be related to its strong adsorption effect, and its capacity to widely remove inflammatory mediators, immune mediators, and endotoxins.


Subject(s)
Hemoperfusion/methods , Pruritus/etiology , Pruritus/therapy , Renal Dialysis/adverse effects , Uremia/etiology , Uremia/therapy , Adult , Aged , C-Reactive Protein , Calcium/blood , Female , Humans , Male , Middle Aged , Parathyroid Hormone/blood , Phosphorus/blood
13.
Article in English | WPRIM | ID: wpr-771016

ABSTRACT

Although methidathion is an organophosphate insecticide, it is different from the other organophosphates in terms of toxicity. Because of its relatively high fat solubility, the apparent volume of methidathion distribution throughout the body is very high, indicating that hemoperfusion is not effective in removing this organophosphate from the body. Redistribution of methidathion from fat to blood can also occur when plasma levels diminish. Additionally, acetylcholinesterase aging, which is the loss of an alkyl side chain that prevents reactivation by oximes, is very rapid so that the effective reactivation by oximes is thwarted. Thus, methidathion's effect on acetylcholinesterase inhibition is long lasting, particularly with a high dose. In addition to its parasympatholytic effect and ability to induce muscle paralysis, methidathion poisoning is associated with a profound and long-lasting circulatory collapse due to sympathetic ganglion blockade. This report presents the case of a 55-year-old man who accidentally ingested a high dose of methidathion. He later developed enteroinvasive aspergillosis infection-induced multiple bowel perforations on two separate occasions while on mechanical ventilator support, resulting in a fatal outcome. The renin-angiotensin axis activated by sympathetic ganglion blockade may have reduced the patient's splanchnic blood flow, contributing to translocation of endotoxin. Also, the effect of excessive acetylcholine on non-neuronal acetylcholine receptors may have contributed to the development of fatal enteroinvasive aspergillosis in this patient.


Subject(s)
Humans , Middle Aged , Acetylcholine , Acetylcholinesterase , Aging , Aspergillosis , Fatal Outcome , Ganglia , Ganglia, Sympathetic , Hemoperfusion , Organophosphate Poisoning , Organophosphates , Oximes , Paralysis , Parasympatholytics , Plasma , Poisoning , Receptors, Cholinergic , Shock , Solubility , Ventilators, Mechanical
14.
Article in English | WPRIM | ID: wpr-20754

ABSTRACT

Although methidathion is an organophosphate insecticide, it is different from the other organophosphates in terms of toxicity. Because of its relatively high fat solubility, the apparent volume of methidathion distribution throughout the body is very high, indicating that hemoperfusion is not effective in removing this organophosphate from the body. Redistribution of methidathion from fat to blood can also occur when plasma levels diminish. Additionally, acetylcholinesterase aging, which is the loss of an alkyl side chain that prevents reactivation by oximes, is very rapid so that the effective reactivation by oximes is thwarted. Thus, methidathion's effect on acetylcholinesterase inhibition is long lasting, particularly with a high dose. In addition to its parasympatholytic effect and ability to induce muscle paralysis, methidathion poisoning is associated with a profound and long-lasting circulatory collapse due to sympathetic ganglion blockade. This report presents the case of a 55-year-old man who accidentally ingested a high dose of methidathion. He later developed enteroinvasive aspergillosis infection-induced multiple bowel perforations on two separate occasions while on mechanical ventilator support, resulting in a fatal outcome. The renin-angiotensin axis activated by sympathetic ganglion blockade may have reduced the patient's splanchnic blood flow, contributing to translocation of endotoxin. Also, the effect of excessive acetylcholine on non-neuronal acetylcholine receptors may have contributed to the development of fatal enteroinvasive aspergillosis in this patient.


Subject(s)
Humans , Middle Aged , Acetylcholine , Acetylcholinesterase , Aging , Aspergillosis , Fatal Outcome , Ganglia , Ganglia, Sympathetic , Hemoperfusion , Organophosphate Poisoning , Organophosphates , Oximes , Paralysis , Parasympatholytics , Plasma , Poisoning , Receptors, Cholinergic , Shock , Solubility , Ventilators, Mechanical
15.
Pediatr Nephrol ; 31(10): 1699-703, 2016 10.
Article in English | MEDLINE | ID: mdl-27335061

ABSTRACT

BACKGROUND: High-dose methotrexate therapy (HDMTX) is a common form of chemotherapy used in children with high-grade malignancy such as osteosarcoma. Treatment with HDMTX requires careful monitoring of drug levels with folinic acid (leucovorin) rescue therapy. Toxicity from methotrexate is not uncommon and sometimes causes significant morbidity and mortality. CASE-DIAGNOSIS/TREATMENT: We report an 11-year-old child whose 24-h post-HDMTX serum level was 651.8 µmol/L (recommended level <20 µmol/L), which was complicated by septic shock and progressive renal and liver failure. As carboxypeptidase (glucarpidase) was not available locally, she was treated with the sequential use of charcoal hemoperfusion (CHP) and single-pass albumin dialysis (SPAD). The patient recovered without complications. Both liver and renal function recovered with no significant late sequelae. CONCLUSION: CHP and SPAD are effective extracorporeal methods of removing methotrexate. They provide alternative treatment options for critical care nephrologists in the management of methotrexate toxicity.


Subject(s)
Acute Kidney Injury/chemically induced , Acute Kidney Injury/therapy , Antidotes/therapeutic use , Antimetabolites, Antineoplastic/adverse effects , Hemoperfusion/methods , Leucovorin/therapeutic use , Methotrexate/adverse effects , Renal Dialysis/methods , Albumins , Antidotes/administration & dosage , Antidotes/pharmacokinetics , Antimetabolites, Antineoplastic/therapeutic use , Charcoal , Child , Female , Humans , Leucovorin/administration & dosage , Methotrexate/pharmacokinetics , Methotrexate/therapeutic use
16.
J Surg Res ; 201(1): 59-68, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26850185

ABSTRACT

BACKGROUND: Direct hemoperfusion with a polymyxin B-immobilized column (PMX-DHP) adsorbs endotoxin and has been used for the treatment of septic shock. Yet, the mechanisms by which PMX-DHP acts on acute kidney injury are only partially understood. MATERIALS AND METHODS: Rats were anesthetized, tracheostomized, and placed on mechanical ventilation. The animals were randomized to three groups: a cecal ligation and puncture (CLP) + dummy-DHP group (n = 10), a CLP + PMX-DHP group (n = 10), and a sham group (n = 4). Four hours after CLP, a dummy-DHP or PMX-DHP was performed for 1 h. The heart rate, mean arterial pressure, arterial blood gases, and plasma concentrations of creatinine, lactate, potassium, interleukin (IL)-6, and IL-10 were measured at 0 h and 8 h. Eight hours after CLP, the kidney was harvested, and histopathologic examination was performed. The expressions of cleaved poly (ADP-ribose) polymerase (PARP) and nuclear factor (NF)-κB p65 were examined by immunohistochemistry. A terminal deoxynucleotide transferase dUTP nick-end labeling assay was performed to detect apoptotic nuclei in kidney sections. RESULTS: PMX-DHP maintained hemodynamics and the acid-base balance and significantly (P < 0.05) decreased the plasma concentrations of lactate, creatinine, potassium, IL-6, and IL-10 compared with dummy-DHP. PMX-DHP significantly (P < 0.001) attenuated the expressions of cleaved PARP and NF-κB p65 in renal tubular cells and renal tubular cell apoptosis compared with dummy-DHP. CONCLUSIONS: These findings suggest that PMX-DHP may protect against acute kidney injury not only by inhibiting the NF-κB signaling pathway but also by preventing renal tubular cell apoptosis.


Subject(s)
Acute Kidney Injury/prevention & control , Anti-Bacterial Agents/therapeutic use , Hemoperfusion , Polymyxin B/therapeutic use , Sepsis/complications , Acute Kidney Injury/etiology , Animals , Disease Models, Animal , Drug Evaluation, Preclinical , Male , Rats, Sprague-Dawley
17.
Anesteziol Reanimatol ; 60(5): 67-70, 2015.
Article in Russian | MEDLINE | ID: mdl-26852584

ABSTRACT

Sepsis is a disease with a high death-rate and is accompanied by profound metabolic disturbances. Interference of microbe metabolic products with biochemical processes in human organism is present in case of severe infection. But there is little information about integration of microbe and human metabolism in septic patients. We evaluated an indol level in healthy individuals and septic patients. It was revealed that septic patients have higher indol levels. Hemoperfusion through "Ovosorb" sorbing agent allows to decrease indol concentration to normal levels. Application of hemosorbtion in combination with magnetic blood processing allows achieving faster and more effective indol removal.


Subject(s)
Hemoperfusion/methods , Indoles/blood , Magnetic Field Therapy/methods , Ovomucin/administration & dosage , Sepsis/microbiology , Sepsis/therapy , APACHE , Adolescent , Adult , Aged , Aged, 80 and over , Humans , Kaplan-Meier Estimate , Middle Aged , Sepsis/blood , Sepsis/mortality , Young Adult
18.
Saudi J Kidney Dis Transpl ; 25(6): 1255-8, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25394445

ABSTRACT

Overdose with calcium channel blockers is uncommon, but is associated with high mortality. The management includes fluid resuscitation, calcium gluconate, glucagon, vasopressors, and high-dose insulin-euglycemia therapy. We describe a rare case of massive overdose of lercanidipine with shock, refractory to conventional therapies and multi-organ failure. Charcoal hemoperfusion with continuous venovenous hemodiafiltration was then used successfully and the patient showed remarkable recovery.


Subject(s)
Amlodipine/poisoning , Antihypertensive Agents/poisoning , Calcium Channel Blockers/poisoning , Charcoal/therapeutic use , Dihydropyridines/poisoning , Drug Overdose/therapy , Hemodiafiltration/methods , Hemoperfusion/methods , Aged , Amlodipine/blood , Antihypertensive Agents/blood , Calcium Channel Blockers/blood , Dihydropyridines/blood , Drug Overdose/blood , Drug Overdose/diagnosis , Drug Overdose/physiopathology , Humans , Male , Multiple Organ Failure/chemically induced , Multiple Organ Failure/therapy , Shock/chemically induced , Shock/therapy , Time Factors , Treatment Outcome
19.
Artif Cells Nanomed Biotechnol ; 42(1): 1-5, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24228783

ABSTRACT

The review is devoted to analysis of the use of carbon sorbents for medicinal purposes in China and description of some innovative technologies in this field in Ukraine. The review underlines the presence of common roots of sorption therapy development in these two countries determined by pioneer works of Prof. T.M.S. Chang, created to the concept of artificial cells. High level of works of Chinese scientists on sorption purification of blood and combined extracorporeal methods has been mentioned. At the same time, by author's opinion, two other methods of sorption therapy, namely enterosorption and sorption therapy of wounds and burns, has not been properly developed in China. In the review, there are also described the essential results of Ukrainian scientists in the field of blood purification from protein-bound toxins and other harmful compounds what is important for treatment of many serious human pathologies, and also the important data on the use of oral sorbents and dressings from activated carbon materials, which could be considered as a useful addition to achievements of Chinese scientists in the field of the development and use of sorbents for medicinal purposes.


Subject(s)
Burns/therapy , Charcoal/therapeutic use , Enterosorption/methods , Hemoperfusion/methods , Mushroom Poisoning/therapy , Organophosphate Poisoning/therapy , Renal Dialysis/methods , Adsorption , China , Enterosorption/statistics & numerical data , Hemoperfusion/statistics & numerical data , Humans , Renal Dialysis/statistics & numerical data , Ukraine
SELECTION OF CITATIONS
SEARCH DETAIL